Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-024830
Filing Date
2025-08-19
Accepted
2025-08-19 16:06:15
Documents
54
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 671542
2 EX-31.1 ex31-1.htm EX-31.1 18925
3 EX-32.1 ex32-1.htm EX-32.1 7253
  Complete submission text file 0001641172-25-024830.txt   3721852

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rtgn-20250630.xsd EX-101.SCH 28164
5 XBRL CALCULATION FILE rtgn-20250630_cal.xml EX-101.CAL 35970
6 XBRL DEFINITION FILE rtgn-20250630_def.xml EX-101.DEF 125144
7 XBRL LABEL FILE rtgn-20250630_lab.xml EX-101.LAB 256380
8 XBRL PRESENTATION FILE rtgn-20250630_pre.xml EX-101.PRE 211057
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 461184
Mailing Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954
Business Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954 415-578-9583
RetinalGenix Technologies Inc. (Filer) CIK: 0001836295 (see all company filings)

EIN.: 823936890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-258528 | Film No.: 251231778
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)